HIGHLIGHTS
- who: Lu Hua from the Medical University, China have published the research work: Safety of chronic high-dose calcium channel blockers exposure in children with pulmonary arterial hypertension, in the Journal: (JOURNAL)
- what: The authors retrospectively reviewed children with IPAH/HPAH who were identified responders in the last 15 years at Fuwai Hospital. The study aimed to determine the maximum CCB dose in these patients and assess the long-term cardiovascular and noncardiovascular safety of CCB therapy. The authors attempted to answer these questions by reviewing the eligible patients to characterize the safety of chronic . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.